BACKGROUND: The choice of first-stage operation in bilio-pancreatic diversion with duodenal switch (BPD-DS) is controversial. There are no published long-term comparisons of one- and two-stage BPD-DS outcomes. METHODS: During 2001-2009, among 1,762 patients scheduled for BPD-DS 48 had duodenal switch (DS) and 53 sleeve gastrectomy (SG) as first-stage procedures. We compared prospectively updated outcomes of 42 DS (100 % open) and 49 SG (88 % laparoscopic), 13 of whom completed their second stage, to a control group of 91 patients with open one-stage BPD-DS. RESULTS: One-year mean percent excess weight loss (%EWL) was greater after SG than DS (47 ± 19 vs. 39 ± 13 SD; p = 0.01) with earlier nadir (16 ± 10 vs. 45 ± 30 months; p < 0.0001) but more rapid significant weight regain. After 5 years, %EWL was 12 ± 35 for 9 SG, 45 ± 19 for 30 DS (p < 0.0006), and 70 ± 18 for the first-stage BPD-DS (p < 0.0001). Weight loss was less after two- than one-stage procedures (p < 0.02). Comorbidities improved progressively between SG, DS and BPD-DS (p < 0.001 for trend). HbA1C decreased by 10, 19, and 31 %, respectively (p < 0.0001). Dyslipidemia was cured in 41, 82, and 100 %, respectively. Systolic and diastolic blood pressure decreased only after DS (12 %; p < 0.0002). Patient satisfaction was similar for SG and DS but greater after BPD-DS overall (p = 0.04). CONCLUSIONS: SG and DS independently contribute to beneficial metabolic outcomes after BPD-DS. Long-term weight loss and correction of metabolic abnormalities were better after DS favoring its use as first stage in BPD-DS; one-stage BPD-DS outcomes were superior to two-staged.
BACKGROUND: The choice of first-stage operation in bilio-pancreatic diversion with duodenal switch (BPD-DS) is controversial. There are no published long-term comparisons of one- and two-stage BPD-DS outcomes. METHODS: During 2001-2009, among 1,762 patients scheduled for BPD-DS 48 had duodenal switch (DS) and 53 sleeve gastrectomy (SG) as first-stage procedures. We compared prospectively updated outcomes of 42 DS (100 % open) and 49 SG (88 % laparoscopic), 13 of whom completed their second stage, to a control group of 91 patients with open one-stage BPD-DS. RESULTS: One-year mean percent excess weight loss (%EWL) was greater after SG than DS (47 ± 19 vs. 39 ± 13 SD; p = 0.01) with earlier nadir (16 ± 10 vs. 45 ± 30 months; p < 0.0001) but more rapid significant weight regain. After 5 years, %EWL was 12 ± 35 for 9 SG, 45 ± 19 for 30 DS (p < 0.0006), and 70 ± 18 for the first-stage BPD-DS (p < 0.0001). Weight loss was less after two- than one-stage procedures (p < 0.02). Comorbidities improved progressively between SG, DS and BPD-DS (p < 0.001 for trend). HbA1C decreased by 10, 19, and 31 %, respectively (p < 0.0001). Dyslipidemia was cured in 41, 82, and 100 %, respectively. Systolic and diastolic blood pressure decreased only after DS (12 %; p < 0.0002). Patient satisfaction was similar for SG and DS but greater after BPD-DS overall (p = 0.04). CONCLUSIONS: SG and DS independently contribute to beneficial metabolic outcomes after BPD-DS. Long-term weight loss and correction of metabolic abnormalities were better after DS favoring its use as first stage in BPD-DS; one-stage BPD-DS outcomes were superior to two-staged.
Authors: Abeezar I Sarela; Simon P L Dexter; Mary O'Kane; Ashok Menon; Michael J McMahon Journal: Surg Obes Relat Dis Date: 2011-07-20 Impact factor: 4.734
Authors: Samuel Klein; Elisa Fabbrini; Bruce W Patterson; Kenneth S Polonsky; Carlos A Schiavon; Jose L Correa; Joao E Salles; Bernardo L Wajchenberg; Ricardo Cohen Journal: Obesity (Silver Spring) Date: 2012-01-19 Impact factor: 5.002
Authors: Maria Laura Cossu; Giuseppe Noya; Gian Carlo Tonolo; Stefano Profili; Giovanni B Meloni; Matteo Ruggiu; Patrizia Brizzi; Franca Cossu; Luca Pilo; Pier Luigi Tilocca Journal: Obes Surg Date: 2004 Nov-Dec Impact factor: 4.129
Authors: N Scopinaro; G F Adami; G M Marinari; E Gianetta; E Traverso; D Friedman; G Camerini; G Baschieri; A Simonelli Journal: World J Surg Date: 1998-09 Impact factor: 3.352
Authors: John G Kral; Swan N Thung; Simon Biron; Frederic-Simon Hould; Stefane Lebel; Simon Marceau; Serge Simard; Picard Marceau Journal: Surgery Date: 2004-01 Impact factor: 3.982
Authors: Paulette Mukorako; Natacha Lemoine; Laurent Biertho; Stéfane Lebel; Marie-Claude Roy; Julie Plamondon; André Tchernof; Thibault V Varin; Fernando F Anhê; David H St-Pierre; André Marette; Denis Richard Journal: Int J Obes (Lond) Date: 2021-10-22 Impact factor: 5.095
Authors: Hinali Zaveri; Amit Surve; Daniel Cottam; Austin Cottam; Walter Medlin; Christina Richards; LeGrand Belnap; Samuel Cottam; Benjamin Horsley Journal: Obes Surg Date: 2018-10 Impact factor: 4.129
Authors: Austin Cottam; Daniel Cottam; Mitchell Roslin; Samuel Cottam; Walter Medlin; Christina Richards; Amit Surve; Hinali Zaveri Journal: Obes Surg Date: 2016-10 Impact factor: 4.129